We are live on ! Find out more
OCEA

Ocean Biomedical, Inc. Common Stock
OCEA

Delisted

OCEA was delisted on the 23rd of April, 2025.

Back to rankings

43 hedge funds and large institutions have $108M invested in Ocean Biomedical, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 6 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

300% more first-time investments, than exits

New positions opened: 4 | Existing positions closed: 1

8% more funds holding

Funds holding: 40 → 43 (+3)

2% more capital invested

Capital invested by funds: $106M → $108M (+$2.19M)

67% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 6

Holders
43
Holders Change
+3
Holders Change %
+7.5%
% of All Funds
0.69%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
6
Closed
1
Calls
$146K
Puts
–
Net Calls
+$146K
Net Calls Change
+$3K

Top Buyers

Rank Fund Capital Flow
1
SFM
Spartan Fund Management
Canada
+$762K
2
HCM
Highbridge Capital Management
New York
+$446K
3
WAM
Warberg Asset Management
Illinois
+$347K
4
SOA
Sea Otter Advisors
Florida
+$257K
5
CSS
Cubist Systematic Strategies
Connecticut
+$120K

Top Sellers

Rank Fund Capital Flow
1
PC
Periscope Capital
Ontario, Canada
-$1.33M
2
CCM
Context Capital Management
California
-$339K
3
CH
CVI Holdings
Delaware
-$101K
4
KIM
Karpus Investment Management
New York
-$90.2K
5
WAM
Wolverine Asset Management
Illinois
-$58K
Name Holding Trade Value Shares
Change 		Change in
Stake
PAMP
1
Polar Asset Management Partners
Ontario, Canada
$8.58M – – –
SCM
2
Shaolin Capital Management
Florida
$8.29M – – –
SCM
3
Saba Capital Management
New York
$7.63M – – –
BFM
4
Boothbay Fund Management
New York
$6.25M -$2.22K -216 -0%
ASM
5
ATW SPAC Management
New York
$6.24M – – –
WAM
6
Weiss Asset Management
Massachusetts
$6.23M – – –
FTCM
7
First Trust Capital Management
Illinois
$5.91M – – –
Hudson Bay Capital Management
8
Hudson Bay Capital Management
Connecticut
$5.49M – – –
D.E. Shaw & Co
9
D.E. Shaw & Co
New York
$5.46M – – –
CCM
10
Context Capital Management
California
$4.83M -$339K -33,024 -7%
MI
11
MMCAP International
Cayman Islands
$4.16M – – –
YCM
12
Yakira Capital Management
Connecticut
$4.16M – – –
WRBC
13
W.R. Berkley Corp
Connecticut
$3.82M – – –
PC
14
Periscope Capital
Ontario, Canada
$3.06M -$1.33M -129,600 -31%
Marshall Wace
15
Marshall Wace
United Kingdom
$2.89M – – –
CH
16
CVI Holdings
Delaware
$2.57M -$101K -9,812 -4%
KIM
17
Karpus Investment Management
New York
$2.48M -$90.2K -8,780 -4%
WP
18
Woodline Partners
California
$2.34M – – –
6CM
19
683 Capital Management
New York
$1.56M – – –
SV
20
Starboard Value
New York
$1.5M – – –
MC
21
Meteora Capital
Florida
$1.44M – – –
KL
22
KIM LLC
Kansas
$1.41M – – –
Calamos Advisors
23
Calamos Advisors
Illinois
$1.3M – – –
WA
24
Whitebox Advisors
Minnesota
$1.07M – – –
Millennium Management
25
Millennium Management
New York
$1.04M – – –
1
2

OCEA Hedge Fund Activity: Q4 2022 in Review

43 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Ocean Biomedical, Inc. Common Stock (OCEA) for Q4 2022, worth a combined $108M — up 2.1% from $106M a quarter earlier.

Buyers outnumbered sellers: 4 funds opened new OCEA positions and 1 closed out — a net gain of 3 holders — while 2 added to existing stakes and 6 trimmed.

The largest buyer was Spartan Fund Management, opening a new position worth an estimated $762K. The largest seller was Periscope Capital, cutting an estimated $1.33M.

  • 43 institutional investors held Ocean Biomedical, Inc. Common Stock (OCEA) as of Q4 2022, up from 40 in Q3 2022.
  • Funds reported $108M of Ocean Biomedical, Inc. Common Stock stock for Q4 2022, up 2.1% quarter-over-quarter.
  • 4 funds opened new Ocean Biomedical, Inc. Common Stock positions in Q4 2022 and 1 closed out, a net change of +3 holders.
  • The largest Ocean Biomedical, Inc. Common Stock buyer in Q4 2022 was Spartan Fund Management, an estimated $762K added.
  • The largest Ocean Biomedical, Inc. Common Stock seller in Q4 2022 was Periscope Capital, an estimated $1.33M sold.

Based on aggregated 13F filings for Q4 2022.